Status:
COMPLETED
Atrial Fibrillation After CABG and PCI
Lead Sponsor:
Region Örebro County
Collaborating Sponsors:
Danderyd Hospital
University Hospital, Linkoeping
Conditions:
Postoperative Atrial Fibrillation
Post PCI Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice and is associated with an increased risk of stroke, heart failure and death. Oral anticoagulation (OAC) is the only tre...
Detailed Description
Atrial fibrillation (AF) is the most common arrhythmia seen in clinical practice and is associated with an increased risk of stroke, heart failure and Death. Oral anticoagulation (OAC) is the only tre...
Eligibility Criteria
Inclusion
- NSTEMI
- Stable or unstable angina requiring revascularization therapy.
- No prior hitory of Atrial Fibrillation
Exclusion
- Previous History of Atrial Fibrillation.
- Any condition that contraindicates oral anticoagulation treatment
Key Trial Info
Start Date :
August 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04307225
Start Date
August 1 2015
End Date
January 1 2022
Last Update
April 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Cardiothoracic and Vascular surgery, Örebro University Hospital
Örebro, Sweden